글로벌 무침약물 전달 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

무침약물 전달 시장 분석

무침투 약물 투여 시장은 특히 백신 접종, 인슐린 투여 장치 , 통증 관리와 같은 분야에서 통증이 없고 효율적인 약물 투여 솔루션에 대한 수요가 증가함에 따라 상당한 성장을 경험하고 있습니다. 이 시장은 제트 인젝터, 스마트 인헤일러 , 경피 패치 와 같은 기술을 활용하여 기존 바늘의 필요성을 없애 환자의 준수를 향상시키고 바늘 찔림 부상 및 감염 위험을 줄입니다. 최근 개발된 제품으로는 배터리 구동 제트 인젝터와 혁신적인 경피 패치가 있으며, 이는 정기적인 약물 복용이 필요한 환자에게 편리한 대안을 제공합니다. 시장 확장은 또한 백신 접종 프로그램을 지원하는 정부 이니셔티브와 만성 질환의 유병률 증가에 의해 촉진됩니다. 무침투 기술의 지속적인 발전은 더 안전하고 접근성이 높은 옵션을 제공하여 약물 투여를 혁신하고 궁극적으로 기존 약물 투여 방법을 재편할 것으로 예상됩니다.

무침투약물 전달 시장 규모

글로벌 무침투 약물 전달 시장 규모는 2023년에 130억 9천만 달러로 평가되었으며, 2031년까지 279억 6천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 9.95%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

무침약물 전달 시장 동향

“ 배터리 구동 제트 인젝터 개발”

무침 투여 시장은 무통 및 편리한 약물 투여에 대한 수요가 증가함에 따라 빠르게 발전하고 있으며, 전통적인 바늘에 대한 의존도를 줄이고 있습니다. 이 시장은 제트 주사기, 흡입기, 경피 패치와 같은 기술을 포괄하며, 환자 경험을 향상시키고 바늘 찔림 부상 및 감염과 관련된 위험을 완화합니다. 혁신을 주도하는 주요 트렌드는 배터리 구동 제트 주사기의 개발로, 정확하고 자동화된 투여를 가능하게 하여 환자가 치료를 더 쉽게 받을 수 있고 덜 위협적으로 받을 수 있게 합니다. 정부 지원 예방 접종 프로그램과 만성 질환의 유병률 증가도 시장 성장을 촉진합니다. 이러한 변화하는 환경은 약물 투여에서 안전성과 사용 편의성을 우선시하는 환자 친화적인 기술 중심 솔루션으로의 전환을 반영합니다.

보고 범위 및 무침약물 전달 시장 세분화  

Needle-Free Drug Delivery Market Definition

Needle-free drug delivery is a method of administering medications without traditional hypodermic needles. It utilizes technologies such as jet injectors, inhalers, and transdermal patches to deliver drugs through the skin or mucous membranes. This approach aims to reduce pain, minimize needle-stick injuries, and enhance patient compliance, providing a safer and more comfortable alternative for routine drug administration.

Needle-Free Drug Delivery Market Dynamics

Drivers

• Growing Prevalence of Cardiovascular Diseases

The growing prevalence of chronic conditions, such as diabetes and cardiovascular diseases, significantly impacts the healthcare landscape, necessitating regular and often complex medication regimens. Patients with these conditions require consistent drug administration to manage their health effectively, which drives the demand for more convenient and less invasive delivery methods. Needle-free drug delivery systems provide a practical solution, allowing patients to self-administer medications with minimal discomfort and reduced risk of infection. This trend is a key market driver, as it aligns with the increasing emphasis on patient-centric care, improving adherence to treatment protocols and enhancing the overall quality of life for those living with chronic illnesses.

•  Increasing Demand for Painless Administration

Patients are increasingly seeking alternatives to traditional needle injections due to the discomfort, pain, and anxiety they often experience. This desire for less invasive options has resulted in a greater acceptance of needle-free technologies, which provide a more comfortable and user-friendly experience for medication administration. Innovations such as jet injectors, inhalers, and transdermal patches are gaining popularity as they eliminate the need for needles while ensuring effective delivery of drugs. This shift in patient preference is a key market driver, as healthcare providers aim to enhance patient satisfaction and compliance, ultimately leading to improved health outcomes and a more positive healthcare experience.

Opportunities

• Focus on Pediatric and Geriatric Care

Catering to pediatric and geriatric populations presents a significant opportunity in the needle-free drug delivery market. Both groups often experience heightened anxiety and fear associated with traditional needle injections, which can lead to avoidance of necessary medical treatments. Needle-free alternatives, such as jet injectors and transdermal patches, offer a more comfortable and less intimidating experience, promoting greater acceptance among these vulnerable populations. By focusing on developing and marketing needle-free solutions specifically designed for children and older adults, companies can enhance patient compliance and improve health outcomes. This growing demand for user-friendly delivery methods highlights a crucial market opportunity for innovation and expansion in this sector.

• Advancement in Smart Delivery Devices

Ongoing innovations in needle-free delivery systems are opening up significant market opportunities for new product launches and expansion. Advancements such as enhanced jet injectors, which improve precision and comfort, along with smart delivery devices that integrate digital technology for real-time monitoring, are transforming how medications are administered. These innovations improve the user experience and cater to the increasing demand for efficient and patient-friendly drug delivery solutions. As healthcare continues to evolve, companies that invest in research and development of these cutting-edge technologies can capitalize on this growing trend, ultimately positioning themselves as leaders in the expanding needle-free drug delivery market.

Restraints/Challenges

• High Development Costs

The research and development of advanced needle-free delivery systems necessitate substantial investment, which poses a significant challenge for smaller companies looking to enter the market. Developing innovative technologies requires financial resources and access to specialized expertise and equipment. This can create barriers for startups and smaller firms that may lack the necessary capital compared to larger, established players. As a result, the high costs associated with R&D can deter these smaller companies from pursuing new needle-free solutions, limiting the diversity of offerings in the market and potentially slowing down overall innovation and competition in the needle-free drug delivery sector.

• Limited Scope of Applications

While needle-free systems offer significant advantages for many medications, their applicability is limited for certain drugs that necessitate precise dosage or specific administration methods. For instance, medications such as biologics or those requiring complex titration may not be suitable for needle-free delivery, as these systems can struggle to ensure the accuracy and consistency needed for optimal therapeutic outcomes. This limitation can reduce the overall market potential for needle-free technologies, as healthcare providers may remain reliant on traditional injection methods for these critical treatments. Consequently, the restricted range of applications poses a significant restraint on the growth and acceptance of needle-free drug delivery systems in clinical settings.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Needle-Free Drug Delivery Market Scope

The market is segmented on the basis of product, technology, application, injection method, and source of power. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Prefilled Needle-Free Injection Systems
• Fillable Needle-Free Injection Systems

Technology

• Inhaler
• Novel Needle-Free
• Jet Injector
• Transdermal Patch

Application

• Insulin Delivery
• Vaccination
• Pediatric Injections
• Pain Management

Injection Method

• Powder Injections
• Liquid Injections
• Depot or Projectile Injection

Source of Power

• Spring Load Jet Injector Systems
• Gas Powered Jet Injector
• Battery Powered Jet Injector System

Needle-Free Drug Delivery Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, technology, application, injection method, and source of power as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the needle-free drug delivery market due to high awareness of the advantages these devices offer. The region benefits from advanced healthcare facilities and significant investments in research and development from both government organizations and pharmaceutical companies, particularly for diabetes and chronic pain management solutions. This strong focus on innovation and patient-centric care is a critical driver for the growth of the needle-free drug delivery market in North America.

Asia-Pacific region is projected to experience significant growth in the needle-free drug delivery market from 2024 to 2031, driven by the increasing prevalence of diabetes in developing countries such as India and China. This rising incidence of diabetes is prompting a demand for more convenient and effective treatment options, making needle-free solutions particularly appealing. As healthcare infrastructure continues to improve in these nations, the adoption of advanced drug delivery systems is expected to accelerate, contributing to the market's expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Needle-Free Drug Delivery Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Needle-Free Drug Delivery Market Leaders Operating in the Market Are:

• Tianjin Xuying Technology Development Co. Ltd. (China)
• Verdict Media Limited(영국)
• 3M(미국)
• PharmaJet(미국)
• UCB SA(미국)
• 이노비오제약(미국)
• 발레리타스 홀딩스(Valeritas Holdings, Inc.) (미국)
• 아크라 데르모젯(프랑스)
• D'Antonio Consultants International Inc. (미국)
• 엔도 주식회사(미국)
• BD(미국)
• CROSSJECT(프랑스)
• Medical International Technologies (MIT Canada) Inc. (캐나다)
• 메드이뮨(미국)
• 미스틱제약(미국)
• 바늘 없는 주사 시스템(네덜란드)
• 이노라이프사이언스(캐나다)
• 페링(네덜란드)
• OptiNose US Inc. (미국)
• 파이저 주식회사(미국)

바늘 없는 약물 전달 시장의 최신 개발

• 2024년 5월, Serum Institute of India(SII)는 무침주사 시스템(NFIS) 기술 역량을 강화하기 위한 전략적 이니셔티브의 일환으로 IntegriMedical의 지분 20%를 인수할 계획이라고 밝혔습니다. 이 투자는 혁신적인 약물 전달 솔루션에 대한 성장하는 시장에서 SII의 입지를 강화하고, 의료 기술 발전에 대한 의지를 뒷받침하는 것을 목표로 합니다. SII는 IntegriMedical과 협력하여 환자 결과를 개선하기 위한 최첨단 무침주사 시스템의 개발 및 구현을 가속화하고자 합니다.
• 2023년 4월, PharmaJet 파트너인 Gennova Biopharmaceuticals는 COVID-19의 오미크론 변종을 표적으로 하는 무침 mRNA 기반 부스터 샷에 대한 데이터를 인도 약물 관리자 총국(DCGI)에 긴급 사용 허가(EUA)를 위해 제출했습니다. 이 제출은 혁신적인 무침 기술을 활용하여 백신 접종 옵션을 확대하는 데 있어 중요한 진전을 나타냅니다. 승인된다면 이 부스터 샷은 환자의 접근성을 높이고 불편함을 줄여 팬데믹과 싸우기 위한 지속적인 노력에 기여할 수 있습니다.
• 2023년 3월, NuGen Medical Devices는 바늘 없는 주사 장치인 InsuJet™의 성능을 강조하는 보고서를 발표했습니다. 이 장치는 기존 바늘 주사에 비해 당뇨병 환자에서 40% 이상 빠른 인슐린 흡수와 상당히 빠른 작용 시작을 보였습니다. 이러한 결과는 네덜란드에서 수행된 여러 임상 연구를 기반으로 하며, 당뇨병 관리 개선에 있어 InsuJet™의 잠재적 이점을 보여줍니다. 이 혁신적인 기술은 인슐린 투여에 대한 유망한 대안을 제공하며, 환자 결과와 편안함을 개선하는 것을 목표로 합니다.
• 2022년 10월, NuGen Medical Devices Inc.는 캐나다에서 5,000회의 인슐린 주사를 제공하도록 설계된 InsuJet 기기를 출시한다고 발표했습니다. 이 혁신적인 기기는 생물학적 폐기물과 바늘 찔림 부상 위험을 최소화하는 동시에 장기 주사 비용을 크게 절감합니다. 또한 InsuJet은 환자에게 보다 편안하고 불안 없는 약물 경험을 제공하여 전반적인 치료 준수와 삶의 질을 향상시킵니다.

SKU-28448